Speaker Profile
PHARMD, Oncology Pharmacy Manager, Wentworth-Douglass
Biography
Suzanne Stevens oversees the oncology pharmacy and is the pharmacogenomic project lead at her organization. Dr. Stevens worked with a team to implement PGx testing in oncology in January 2022 and lead a team of pharmacists as part of the ASHP Pharmacogenomics Accelerator Program beginning in September, 2023. She is a board certified oncology pharmacist and has been practicing in oncology pharmacy in different roles for the last 25 years. She has also completed certificate programs in Pharmacogenomics as well as Precision Medicine in Oncology Genomics.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair:
Kristine Ashcraft, YouScript
Program Theme: Addressing Persistent PGx Myths
- PMWC 2025 Award Ceremony:
Luminary Honoree: Philip E. Empey, UPMC
Pioneer Honoree: Collen Masimirembwa, University of the Witwatersrand
- Keynote: Genomic Diversity in Africa: Pharmacogenetics and Clinical Applications
- Collen Masimirembwa, University of the Witwatersrand
- PGx is Expensive and Insurance Coverage is Limited (PANEL)
Chair: Jai Patel, Atrium Health
- Lena Chaihorskym, Alva10
- Mark Fleury, ACS CAN
- Kristine Ashcraft, YouScript
- Alison L. Quinn, Kaiser - Science Backing PGx is Limited (PANEL)
Chair: Sara Rogers, American Society of Pharmacovigilance
- Russ Altman, Stanford
- Philip E. Empey, UPMC
- Jeff Shaman, Coriell Life Sciences
- PGx is Hard to Implement (PANEL)
Chair: Kristine Crews, St Jude
- Suzanne Stevens, Wentworth-Douglass Hospital
- Deepak Voora, VA
- Jennifer Wick, The Christ Hospital Health Network
- Latha Palaniappan, Stanford - Fireside Chat
Chair: Damon Hostin, Illumina
- Dan Hertz, University of Michigan - What will It Take to Make PGx the Standard of Care? (PANEL)
Chair: Kristine Ashcraft, YouScript
- Alan Venook, UCSF/ NCCN
- Gary Marchant, ASU
- Dan Hertz, University of Michigan
- Deepak Voora, VA
